Marrone Bio Innovations, Inc.
MBII
MBII was delisted on the 12th of July, 2022.
71 hedge funds and large institutions have $46.4M invested in Marrone Bio Innovations, Inc. in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 29 reducing their positions, and 13 closing their positions.
42% more capital invested
Capital invested by funds: $32.6M → $46.4M (+$13.8M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 74 → 71 (-3)
15% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 13
52% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 29
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
E
Ergoteles
New York
|
+$684K |
| 2 |
GLAM
Gardner Lewis Asset Management
Chadds Ford,
Pennsylvania
|
+$536K |
| 3 |
AGM
Alpine Global Management
New York
|
+$184K |
| 4 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$175K |
| 5 |
VIA
Vident Investment Advisory
Alpharetta,
Georgia
|
+$109K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Shay Capital
New York
|
-$1.23M |
| 2 |
AG
Artal Group
Luxembourg
|
-$755K |
| 3 |
JG
Jefferies Group
New York
|
-$533K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$307K |
| 5 |
Morgan Stanley
New York
|
-$179K |
MBII Hedge Fund Activity: Q1 2022 in Review
71 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q1 2022, worth a combined $46.4M — up 42% from $32.6M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of MBII and 11 opened new positions — a net loss of 2 holders — while 29 trimmed existing stakes and 14 added.
The largest buyer was Ergoteles, opening a new position worth an estimated $684K. The largest seller was Shay Capital, cutting an estimated $1.23M.
- 71 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q1 2022, down from 74 in Q4 2021.
- Funds reported $46.4M of Marrone Bio Innovations, Inc. stock for Q1 2022, up 42% quarter-over-quarter.
- 11 funds opened new Marrone Bio Innovations, Inc. positions in Q1 2022 and 13 closed out, a net change of -2 holders.
- The largest Marrone Bio Innovations, Inc. buyer in Q1 2022 was Ergoteles, an estimated $684K added.
- The largest Marrone Bio Innovations, Inc. seller in Q1 2022 was Shay Capital, an estimated $1.23M sold.
Based on aggregated 13F filings for Q1 2022.